SUMMARY Lysosomal ultrastructure in circulating lymphocytes and neutrophils from the blood of 22 patients with rheumatoid arthritis or systemic lupus erythematosus undergoing chloroquine therapy has been examined and compared with that of rheumatoid cases receiving alternative forms of treatment and non-rheumatoid controls. The lymphocytes of all 22 patients receiving chloroquine showed a highly significant number of lamellar inclusion bodies (mean 9-3%) compared with only occasional inclusions in six of the 14 rheumatoid and four of the 12 non-rheumatoid controls (means 0-86% and 0-83% respectively). Neutrophils from eight chloroquine-treated patients also showed abnormal granules which were absent from both control groups. These findings confirm our earlier in vitro work which indicated that lymphocytes, compared with neutrophils, had a greater susceptibility to chloroquine action with respect to alterations in lysosomal structure.
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We have recently demonstrated' that exposure of normal human circulating leucocytes to therapeutic concentrations of chloroquine (5-0.05 [ig/ml) for four hours in vitro produces a significant increase in the number of autophagosomes in lymphocytes, while neutrophils appear to be unaffected by the drug. To establish whether this finding occurs in vivo during chloroquine therapy we have undertaken a study of lysosomal ultrastructure in circulating leucocytes from patients with rheumatoid arthritis and systemic lupus erythematosus receiving chloroquine for periods ranging from two days to 20 months.
Materials and methods
Three groups of subjects were examined: (1) Chloroquine treated group: 22 patients receiving chloroAccepted for publication 3 April 1984. Correspondence to Dr C. J. P. Jones (Fig. 1) . The frequency of affected cells ranged from 1 to 20% with a mean of 9-3% inclusions per cell sample. Cells containing abundant parallel tubular arrays and/or with a 'hand mirror' configuration were generally devoid of these inclusions, which were usually to be found in small round cells with a high nucleo-cytoplasmic ratio, occasional strands of rough endoplasmic reticulum, and sparse organelles. The inclusions were frequently located opposite the identation or cleft in the nucleus when this was present. Similar inclusions were also found in occasional control cells. Six of the 14 patients with rheumatoid disease and four of the 12 non-rheumatoid controls were thus affected, with a maximum frequency of two involved cells, and means of 0-86% and 0.83% inclusions per cell sample respectively (see Tables 2 and 3 ). There was Table 1 .
group.bmj.com on January 28, 2018 -Published by http://ard.bmj.com/ Downloaded from Table 3 During an in vitro investigation on the effect of chloroquine on leucocytes' we found that incubation in 5-O*05 Rg/ml chloroquine for four hours produced a dose-related increase in the number of lymphocytes containing autophagosomes while having no apparent effect on leucocyte ultrastructure. The greater susceptibility of lymphocytes to the action of chloroquine has been confirmed in this in vivo study, as inclusions were found in every case in lymphocytes, but only eight out of 22 cases showed abnormalities in the circulating neutrophils. In general it was found that high numbers of inclusions in the lymphocyte population were associated with affected neutrophils. Similar inclusions were also found in control lymphocytes, though the number of affected cells was much lower. There are several possible explanations for this:
(1) Chloroquine increases the incidence of a natural phenomenon (e.g., the existence of myelin bodies) which is found in normal circulating cells.
(2) The myelin bodies found in normal lymphocytes are artefacts produced by glutaraldehyde fixation, which permits the leaching out of lipid from cytomembranes, allowing it to mix with an aqueous environment and produce lamellar formations; these are subsequently fixed by the osmium tetroxide used at a later stage of processing. 
